Roivant Sciences LtdNASDAQ:ROIV
- LAST PRICE11.7600
- TODAY'S CHANGE (%)0.0100 (0.0851%)
- Bid / Lots11.6000/ 38
- Ask / Lots12.0000/ 9
- Open / Previous Close11.6800 / 11.7500
- Day Range
- 52 Week Range
- Volume2,584,826
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ROIV |
|---|---|---|
| 09:32 ET | 25583 | 11.74 |
| 09:33 ET | 11788 | 11.795 |
| 09:35 ET | 7546 | 11.79 |
| 09:37 ET | 10964 | 11.82 |
| 09:39 ET | 1643 | 11.82 |
| 09:42 ET | 9862 | 11.85 |
| 09:44 ET | 15108 | 11.845 |
| 09:46 ET | 8846 | 11.8299 |
| 09:48 ET | 16073 | 11.815 |
| 09:50 ET | 14168 | 11.82 |
| 09:51 ET | 29569 | 11.82 |
| 09:53 ET | 11164 | 11.795 |
| 09:55 ET | 13466 | 11.795 |
| 09:57 ET | 6443 | 11.8 |
| 10:00 ET | 1950 | 11.81 |
| 10:02 ET | 2849 | 11.805 |
| 10:04 ET | 5613 | 11.78 |
| 10:06 ET | 4974 | 11.79 |
| 10:08 ET | 7594 | 11.785 |
| 10:09 ET | 3551 | 11.78 |
| 10:11 ET | 3633 | 11.79 |
| 10:13 ET | 4900 | 11.77 |
| 10:15 ET | 9637 | 11.775 |
| 10:18 ET | 2177 | 11.76 |
| 10:20 ET | 3120 | 11.755 |
| 10:22 ET | 17698 | 11.76 |
| 10:24 ET | 1500 | 11.755 |
| 10:26 ET | 5991 | 11.78 |
| 10:27 ET | 13239 | 11.785 |
| 10:29 ET | 900 | 11.79 |
| 10:31 ET | 9027 | 11.79 |
| 10:33 ET | 6198 | 11.796946 |
| 10:36 ET | 5325 | 11.795 |
| 10:38 ET | 2964 | 11.8 |
| 10:40 ET | 4600 | 11.805 |
| 10:42 ET | 6540 | 11.8 |
| 10:44 ET | 1035 | 11.805 |
| 10:45 ET | 20701 | 11.81 |
| 10:47 ET | 4201 | 11.81 |
| 10:49 ET | 8412 | 11.825 |
| 10:51 ET | 2655 | 11.835 |
| 10:54 ET | 2406 | 11.835 |
| 10:56 ET | 6187 | 11.82 |
| 10:58 ET | 3492 | 11.815 |
| 11:00 ET | 3017 | 11.81 |
| 11:02 ET | 7714 | 11.815 |
| 11:03 ET | 14257 | 11.805 |
| 11:05 ET | 2165 | 11.805 |
| 11:07 ET | 14663 | 11.8 |
| 11:09 ET | 4214 | 11.805 |
| 11:12 ET | 7423 | 11.78 |
| 11:14 ET | 22218 | 11.785 |
| 11:16 ET | 4234 | 11.79 |
| 11:18 ET | 5307 | 11.78 |
| 11:20 ET | 8185 | 11.7752 |
| 11:21 ET | 7673 | 11.79 |
| 11:23 ET | 3328 | 11.78 |
| 11:25 ET | 10546 | 11.7802 |
| 11:27 ET | 2264 | 11.795 |
| 11:30 ET | 6486 | 11.78 |
| 11:32 ET | 1879 | 11.78 |
| 11:34 ET | 769 | 11.78 |
| 11:36 ET | 1613 | 11.79 |
| 11:38 ET | 9002 | 11.78 |
| 11:39 ET | 1760 | 11.77 |
| 11:41 ET | 4047 | 11.76 |
| 11:43 ET | 500 | 11.76 |
| 11:45 ET | 17334 | 11.76 |
| 11:48 ET | 3031 | 11.7601 |
| 11:50 ET | 600 | 11.76 |
| 11:52 ET | 7891 | 11.765 |
| 11:54 ET | 3265 | 11.765 |
| 11:56 ET | 10345 | 11.78 |
| 11:57 ET | 4801 | 11.78 |
| 11:59 ET | 1316 | 11.77 |
| 12:01 ET | 4933 | 11.765 |
| 12:03 ET | 4502 | 11.765 |
| 12:06 ET | 24010 | 11.775 |
| 12:08 ET | 5838 | 11.785 |
| 12:10 ET | 5552 | 11.79 |
| 12:12 ET | 1375 | 11.8 |
| 12:14 ET | 65973 | 11.795 |
| 12:15 ET | 10157 | 11.795 |
| 12:17 ET | 35558 | 11.809 |
| 12:19 ET | 37410 | 11.805 |
| 12:21 ET | 14514 | 11.8 |
| 12:24 ET | 10654 | 11.7976 |
| 12:26 ET | 4879 | 11.795 |
| 12:28 ET | 2326 | 11.8 |
| 12:30 ET | 6012 | 11.79 |
| 12:32 ET | 7917 | 11.805 |
| 12:33 ET | 1717 | 11.8 |
| 12:35 ET | 7062 | 11.795 |
| 12:37 ET | 313 | 11.795 |
| 12:39 ET | 553 | 11.8 |
| 12:42 ET | 893 | 11.8 |
| 12:44 ET | 12484 | 11.805 |
| 12:46 ET | 1279 | 11.805 |
| 12:48 ET | 6373 | 11.795 |
| 12:50 ET | 200 | 11.795 |
| 12:51 ET | 8671 | 11.785 |
| 12:53 ET | 15675 | 11.795 |
| 12:55 ET | 4202 | 11.785 |
| 12:57 ET | 596 | 11.785 |
| 01:00 ET | 100 | 11.785 |
| 01:02 ET | 575 | 11.785 |
| 01:04 ET | 726 | 11.7802 |
| 01:06 ET | 487 | 11.785 |
| 01:08 ET | 552 | 11.78 |
| 01:09 ET | 200 | 11.79 |
| 01:11 ET | 5600 | 11.78 |
| 01:13 ET | 14269 | 11.78 |
| 01:15 ET | 31792 | 11.775 |
| 01:18 ET | 15438 | 11.775 |
| 01:20 ET | 1329 | 11.775 |
| 01:22 ET | 15286 | 11.785 |
| 01:24 ET | 2101 | 11.785 |
| 01:26 ET | 10079 | 11.8 |
| 01:27 ET | 6273 | 11.795 |
| 01:29 ET | 11917 | 11.8 |
| 01:31 ET | 7097 | 11.795 |
| 01:33 ET | 11580 | 11.79 |
| 01:36 ET | 4282 | 11.785 |
| 01:38 ET | 7692 | 11.79 |
| 01:40 ET | 611 | 11.795 |
| 01:42 ET | 11580 | 11.785 |
| 01:44 ET | 8672 | 11.78 |
| 01:45 ET | 3133 | 11.775 |
| 01:47 ET | 8470 | 11.78 |
| 01:49 ET | 479 | 11.78 |
| 01:51 ET | 2022 | 11.789 |
| 01:54 ET | 1455 | 11.79 |
| 01:56 ET | 4208 | 11.795 |
| 01:58 ET | 2207 | 11.795 |
| 02:00 ET | 3084 | 11.785 |
| 02:02 ET | 17367 | 11.795 |
| 02:03 ET | 5816 | 11.79 |
| 02:05 ET | 2202 | 11.785 |
| 02:07 ET | 16744 | 11.79 |
| 02:09 ET | 4182 | 11.79 |
| 02:12 ET | 3687 | 11.79 |
| 02:14 ET | 1532 | 11.79 |
| 02:16 ET | 6857 | 11.795 |
| 02:18 ET | 7014 | 11.8 |
| 02:20 ET | 12623 | 11.79 |
| 02:21 ET | 10724 | 11.785 |
| 02:23 ET | 8340 | 11.77 |
| 02:25 ET | 1897 | 11.775 |
| 02:27 ET | 4767 | 11.785 |
| 02:30 ET | 3039 | 11.8 |
| 02:32 ET | 5466 | 11.795 |
| 02:34 ET | 17613 | 11.8 |
| 02:36 ET | 14111 | 11.795 |
| 02:38 ET | 923 | 11.79 |
| 02:39 ET | 6730 | 11.795 |
| 02:41 ET | 3982 | 11.78 |
| 02:43 ET | 13487 | 11.785 |
| 02:45 ET | 3354 | 11.805 |
| 02:48 ET | 9520 | 11.8 |
| 02:50 ET | 8416 | 11.805 |
| 02:52 ET | 11252 | 11.815 |
| 02:54 ET | 11293 | 11.81 |
| 02:56 ET | 7486 | 11.79 |
| 02:57 ET | 24837 | 11.805 |
| 02:59 ET | 7893 | 11.805 |
| 03:01 ET | 5101 | 11.8 |
| 03:03 ET | 3948 | 11.8 |
| 03:06 ET | 4155 | 11.8 |
| 03:08 ET | 3118 | 11.8047 |
| 03:10 ET | 10306 | 11.805 |
| 03:12 ET | 16351 | 11.81 |
| 03:14 ET | 7733 | 11.815 |
| 03:15 ET | 6205 | 11.835 |
| 03:17 ET | 880 | 11.835 |
| 03:19 ET | 1147 | 11.84 |
| 03:21 ET | 24341 | 11.845 |
| 03:24 ET | 14339 | 11.845 |
| 03:26 ET | 1844 | 11.85 |
| 03:28 ET | 3880 | 11.84 |
| 03:30 ET | 2844 | 11.845 |
| 03:32 ET | 8014 | 11.835 |
| 03:33 ET | 3956 | 11.83 |
| 03:35 ET | 10601 | 11.83 |
| 03:37 ET | 3172 | 11.84 |
| 03:39 ET | 5387 | 11.82 |
| 03:42 ET | 1379 | 11.825 |
| 03:44 ET | 8479 | 11.81 |
| 03:46 ET | 5346 | 11.805 |
| 03:48 ET | 15332 | 11.8 |
| 03:50 ET | 3631 | 11.805 |
| 03:51 ET | 46313 | 11.795 |
| 03:53 ET | 8788 | 11.785 |
| 03:55 ET | 87192 | 11.78 |
| 03:57 ET | 25554 | 11.765 |
| 04:00 ET | 459120 | 11.76 |
Nov 5, 2024
DJ Organon: FDA Extends Vtama Atopic-Dermatitis Review to March, from 8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 29, 2024
Oct 28, 2024
Press Release: Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%, from 9:25AM ET on Monday Oct 28, 2024 by Dow Jones
9:25AM ET on Monday Oct 28, 2024 by Dow JonesOrganon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1%, from 9:25AM ET on Monday Oct 28, 2024 by Dow Jones
9:25AM ET on Monday Oct 28, 2024 by Dow Jones*DJ Organon Completes Acquisition Of Dermavant, Including Innovative Dermatologic Therapy, VTAMA(R) (tapinarof) Cream, 1% >OGN, from 9:25AM ET on Monday Oct 28, 2024 by Dow Jones
9:25AM ET on Monday Oct 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Roivant Sciences Ltd | 8.7B | 2.1x | --- |
Corcept Therapeutics Inc | 5.7B | 42.8x | +9.80% |
Ligand Pharmaceuticals Inc | 2.1B | 58.4x | -12.71% |
Harrow Inc | 1.7B | -52.5x | --- |
Ocular Therapeutix Inc | 1.7B | -9.9x | --- |
Immunocore Holdings PLC | 1.7B | -32.1x | --- |
Company Information
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes product candidates across various therapeutic areas, including immunology, oncology, hematology, and dermatology. Its pipeline includes IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; brepocitinib, a small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis and non-infectious uveitis; mosliciguat, an inhaled soluble sGC activator in development for pulmonary hypertension associated with interstitial lung disease, in addition to other clinical-stage molecules; and namilumab, is a fully human monoclonal antibody targeting granulocyte-macrophage colony stimulating factor, an inflammatory cytokine involved in inflammatory disorders such as sarcoidosis.
Contact Information
- Headquarters
- 11-12 St. James's Square Suite 1, 3rd FloorLONDON, United Kingdom SW1Y4LB
- Phone
- 207-400-3347
- Fax
- ---
Executives
- Independent Chairman of the Board
- Ilan Oren
- President, Chief Operating Officer
- Eric Venker
- President, Chief Investment Officer, Director
- Mayukh Sukhatme
- Chief Executive Officer, Director
- Matthew Gline
- Chief Financial Officer
- Richard Pulik
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.7B |
|---|---|
Revenue (TTM) | $158.3M |
Shares Outstanding | 739.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $5.57 |
Book Value | $7.40 |
P/E Ratio | 2.1x |
Price/Sales (TTM) | 54.9 |
Price/Cash Flow (TTM) | 1.9x |
Operating Margin | 2,799.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
